Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib

NCT03778229

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Washington D.C., District of Columbia, United States
View all 90 locations
View Trial Details
Active, Not Recruiting

Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations

NCT05687266

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
View all 254 locations
View Trial Details
Active, Not Recruiting

A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

NCT06544655

Conditions
Advanced Solid Tumors, Brain Diseases, Bronchial Neoplasms, +33 more
Locations
  • Local Institution - 0003 Tucson, Arizona, United States
  • Local Institution - 0007 Los Angeles, California, United States
  • Local Institution - 0011 Grand Rapids, Michigan, United States
  • Local Institution - 0004 Sioux Falls, South Dakota, United States
View Trial Details
Active, Not Recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT03909334

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations
  • Georgetown University Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Rush University Medical Center Chicago, Illinois, United States
View Trial Details
Active, Not Recruiting

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

NCT05633602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 566 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)

NCT06049212

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Aichi Cancer Center ( Site 0006) Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East ( Site 0002) Kashiwa, Chiba, Japan
  • National Hospital Organization Shikoku Cancer Center ( Site 0008) Matsuyama, Ehime, Japan
  • Kanagawa Cancer Center ( Site 0004) Yokohama, Kanagawa, Japan
View Trial Details
Active, Not Recruiting

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

NCT03157128

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Any Solid Tumor, +46 more
Locations
  • Mayo Clinic of Scottsdale Scottsdale, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 85 locations
View Trial Details

Related conditions